A Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of a 13-valent Pneumococcal Conjugate Vaccine in Japanese Elderly Adults Aged 65 Years Old and Older

Clinical trial NCT01646398 · COMPLETED

Trial details

NCT number: NCT01646398
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pneumococcal Vaccines Pneumococcal Conjugate Vaccine

Start date: 2012-06-01
Primary completion: 2012-10-01
Enrollment: 764

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.